Gamin Kim

This study identifies TOX as a critical regulator of tumor-infiltrating regulatory T cells, showing its role in maintaining immunosuppression and its potential as a therapeutic target.

The paper uses single-cell multi-omics to identify immunosuppressive factors in ALK-positive lung cancer that contribute to poor immunotherapy responses.